Fig. 1: Trial profile with patient disposition.
R-CHOP, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.
Fig. 1: Trial profile with patient disposition. | Nature Communications
R-CHOP, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.
